Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 3:14 PM
Ignite Modification Date: 2025-12-25 @ 1:36 PM
NCT ID: NCT03163992
Description: None
Frequency Threshold: 0
Time Frame: 2 year
Study: NCT03163992
Study Brief: Pembrolizumab in Advanced Hepatocellular Carcinoma as Second-line Treatment After Failure of Sorafenib
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Pembrolizumab Pembrolizumab (MK-3475) 200 mg every 3 weeks (Q3W) Pembrolizumab: Pembrolizumab (MK-3475) 200 mg every 3 weeks (Q3W) 35 None 8 60 24 60 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
fatigue SYSTEMATIC_ASSESSMENT General disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
pruritis SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
elevated liver enzyme SYSTEMATIC_ASSESSMENT Hepatobiliary disorders None View
hyperbilirubinemina SYSTEMATIC_ASSESSMENT Hepatobiliary disorders None View
diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
constipation SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
hyperthyroidism SYSTEMATIC_ASSESSMENT Endocrine disorders None View